Answers are grounded in this paper and cite their sources.
Higher cellular stress responses predict blood pressure variability in older adults, suggesting adropin's role as a biomarker.
Hypertension and elevated visit-to-visit variability in blood pressure (BP) increase lifetime risk of cardiovascular, kidney, and neurodegenerative diseases. Adropin, a hepatokine with autocrine/paracrine actions, contributes to cardiometabolic crosstalk and mediates cellular stress responses across metabolic and cardiovascular tissues. Human cross-sectional and exercise studies suggest links between adropin, endothelial function, and vascular elasticity. Whether circulating adropin levels reflect risk of poor BP control remains unclear. We examined relationships between plasma adropin concentrations, BP, and visit-to-visit BP variability in older, community-dwelling participants from Multidomain Alzheimer Prevention Trial (MAPT: N=443; mean±SD age, 75.9±4.5 years; 60% female). Supine BP and heart rate were assessed every 6 months for 5 years (8.1±1.3 measurements/participant). Multivariate regression modeling revealed a positive association between adropin and variation independent of the mean (VIM) in systolic BP (R=0.329, F 7,429 =7.454, p<0.001). Predictors included adropin (β=0.165, p<0.001), age (β=0.146, p<0.005), sex (male=1, female=0; β=−0.130, p=0.005), and antihypertensive medication use (yes=1, no=0; β=0.188, p<0.001). Stratification by medication use suggested the association between adropin and systolic BP VIM is confined to participants on antihypertensive therapy (R=0.347, F 6,188 =4.302, p<0.001; adropin, β=0.233, p=0.001). However, analysis by grouping participants in tertiles ranked by adropin or systolic BP VIM suggests that, while the relationship is notably weaker, it is not absent for participants not on antihypertensive medications. In conclusion, elevated plasma adropin concentrations associate with systolic BP variability in older hypertensive adults. These findings identify adropin as a potential biomarker of poor BP control.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: